Angela Zhu

Angela Zhu

Auto-generated profile, based on publicly available information

Angela Zhu

Division of Hospital Medicine, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
TSTammy Stump
Tammy Stump
SFSuzanne Fastner
Suzanne Fastner
YJYeonjung Jo
Yeonjung Jo
JCJonathan Chipman
Jonathan Chipman
BHBenjamin Haaland
Benjamin Haaland
YWYelena P. Wu
Yelena P. Wu
Ultraviolet radiation (UVR) exposure is the primary modifiable risk factor for melanoma. Wearable UVR sensors provide a means of quantifying UVR exposure objectively and with a lower burden than self-report measures used in most research. The purpose of this study was to evaluate the relationship between detected UVR exposure and reported sunburn occurrence. In this study, a UVR monitoring device was worn by 97 parent–child dyads during waking hours for 14 days to measure instantaneous and accumulated UVR exposure. The results showed that the participants’ total UVR exposure was associated with reported sunburn after adjusting for Fitzpatrick skin type and geographic location. It was observed that one standard erythemal dose (SED) increase in the participants’ daily total UVR exposure was associated with reported sunburn (an odds ratio (OR) of 1.26 with a 95% CI of 1.13 and 1.41, and p < 0.001 for parents and an OR of 1.28 with a 95% CI of 1.12 and 1.47, and p < 0.001 for children). A one-SED increase in the participants’ UVR exposure from 10 am to 4 pm was also associated with reported sunburn (an OR of 1.31 with a 95% CI of 1.15 and 1.49, and p < 0.001 for parents and an OR of 1.33 with a 95% CI of 1.12 and 1.59, and p = 0.001 for children). We found that elevated UVR exposure recordings measured by the UVR sensor were associated with reported sunburn occurrence. Future directions for wearable UVR sensors may include their use as an intervention tool to support in-the-moment sunburn prevention.

29 April 2020 in JMIR Dermatology
Verified
Journal Article
Open access
ENElizabeth Sela Nagelhout
Elizabeth Sela Nagelhout
RLRiley Lensink
Riley Lensink
AZAngela Zhu
Angela Zhu
BPBridget G Parsons
Bridget G Parsons
JJJakob D Jensen
Jakob D Jensen
YWYelena P Wu
Yelena P Wu
Background: In the United States, melanoma is the fifth most common type of cancer. Reducing UV radiation (UVR) exposure is essential for the prevention of melanoma. The assessment of individual-level UVR exposure using wearable technology is a promising method to monitor and reduce UVR exposure. However, the feasibility and acceptability of using wearable UVR monitoring devices have not been assessed. Objective: This study aimed to assess the feasibility and acceptability of using a commercially available UVR monitoring wearable device in adults and children. Methods: We recruited families (1 parent and 1 child) to test a new, commercially available UVR monitoring device (namely, Shade). Participants wore Shade for 2 weeks and completed questionnaires assessing the feasibility and acceptability of wearing the device. Qualitative analyses were conducted to summarize participants’ open-ended responses regarding device feasibility. Results: A total of 194 individuals (97 adults and 97 children) participated in this study. The participating children were aged, on average, 12.7 years. Overall, adults and children reported moderate satisfaction with wearing Shade. The feasibility of the use of Shade was adequate, with 73% (65/89) of adults and 61% (54/89) of children reporting that they wore the device “all of the time they were outside.” Through open-ended responses, participants reported that the device was easy to use, was compact, and increased their awareness about their exposure to UVR. Conclusions: Adults and children can feasibly use a wearable UVR monitoring device, and the use of the device was acceptable to participants. The device could be integrated into melanoma preventive interventions to increase individuals’ and families’ awareness of UVR exposure and to facilitate the use of recommended melanoma preventive strategies.

28 September 2021 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
BPBridget G Parsons
Bridget G Parsons
ENElizabeth S Nagelhout
Elizabeth S Nagelhout
AWAli P Wankier
Ali P Wankier
Nan HuNan Hu
Nan Hu
RLRiley Lensink
Riley Lensink
YWYelena P Wu
Yelena P Wu
Background: Emerging UV radiation (UVR) monitoring devices may present an opportunity to integrate such technology into skin cancer prevention interventions. However, little is known about the effects of using a wearable UVR monitor on adults’ and children’s sun protection–related behaviors and attitudes (eg, cancer worry and perceived risk). Understanding the potential role of reactivity and seasonal effects will help inform the use of objective monitors in the context of skin cancer prevention research, including intervention studies. Objective: The aim of this study is to examine the potential reactivity associated with a wearable personal UVR monitor, specifically the effects associated with reported sun-protective behaviors and skin cancer–related attitudes, which are often the targets of skin cancer preventive interventions. Methods: Child-parent dyads (n=97 dyads) were asked to wear a UVR monitoring device during waking hours for 2 weeks. Participants were asked to sync the device daily with a smartphone app that stored the UVR exposure data. Participants were blinded to their UVR exposure data during the 2-week period; thus, the smartphone app provided no feedback to the participants on their UVR exposure. Participants completed self-report questionnaires assessing sun-protective behaviors, sunburn, tanning, skin self-examination, skin cancer–related knowledge, perceived risk, cancer worry, response efficacy, and intentions to change behaviors over the 2-week period. Linear regressions were conducted to investigate changes in the outcomes over time and to account for the role of the season of study participation. Results: Regression results revealed that there was a significant decrease over time for several sun protection outcomes in children, including time spent outdoors on weekends (P=.02) and weekdays (P=.008), sunscreen use (P=.03), reapplication (P<.001), and unintentional tanning (P<.001). There were no significant changes over time in children’s and parents’ UVR exposure, sunburn occurrence, or sun protection attitudes. Season of participation was associated with several outcomes, including lower sunscreen use (P<.001), reapplication (P<.001), sunburns (P=.01), intentions to change sun-protective behaviors (P=.02), and intentional (P=.008) and unintentional tanning (P=.01) for participants who participated in the fall versus the summer. Conclusions: The findings from this study suggest that daily use of a UVR monitoring device over a 2-week period may result in changes in certain sun-protective behaviors. These results highlight the importance of identifying and addressing potential reactivity to UVR monitoring devices, especially in the context of skin cancer preventive intervention research. Ultimately, objectively assessed UVR exposure could be integrated into the outcome assessment for future testing of skin cancer prevention interventions.

Verified
Journal Article
Open access
PDF file
FNFlory Nkoy
Flory Nkoy
BSBryan L. Stone
Bryan L. Stone
CDCassandra Deering-Rice
Cassandra Deering-Rice
AZAngela Zhu
Angela Zhu
JLJohn G. Lamb
John G. Lamb
CRChristopher A. Reilly
Christopher A. Reilly
Genetic variation among inhaled corticosteroid (ICS)-metabolizing enzymes may affect asthma control, but evidence is limited. This study tested the hypothesis that single-nucleotide polymorphisms (SNPs) in Cytochrome P450 3A5 (CYP3A5) would affect asthma outcomes. Patients aged 2–18 years with persistent asthma were recruited to use the electronic AsthmaTracker (e-AT), a self-monitoring tool that records weekly asthma control, medication use, and asthma outcomes. A subset of patients provided saliva samples for SNP analysis and participated in a pharmacokinetic study. Multivariable regression analysis adjusted for age, sex, race, and ethnicity was used to evaluate the impact of CYP3A5 SNPs on asthma outcomes, including asthma control (measured using the asthma symptom tracker, a modified version of the asthma control test or ACT), exacerbations, and hospital admissions. Plasma corticosteroid and cortisol concentrations post-ICS dosing were also assayed using liquid chromatography–tandem mass spectrometry. Of the 751 patients using the e-AT, 166 (22.1%) provided saliva samples and 16 completed the PK study. The e-AT cohort was 65.1% male, and 89.6% White, 6.0% Native Hawaiian, 1.2% Black, 1.2% Native American, 1.8% of unknown race, and 15.7% Hispanic/Latino; the median age was 8.35 (IQR: 5.51–11.3) years. CYP3A5*3/*3 frequency was 75.8% in White subjects, 50% in Native Hawaiians and 76.9% in Hispanic/Latino subjects. Compared with CYP3A5*3/*3, the CYP3A5*1/*x genotype was associated with reduced weekly asthma control (OR: 0.98; 95% CI: 0.97–0.98; p < 0.001), increased exacerbations (OR: 6.43; 95% CI: 4.56–9.07; p < 0.001), and increased asthma hospitalizations (OR: 1.66; 95% CI: 1.43–1.93; p < 0.001); analysis of 3/*3, *1/*1 and *1/*3 separately showed an allelic copy effect. Finally, PK analysis post-ICS dosing suggested muted changes in cortisol concentrations for patients with the CYP3A5*3/*3 genotype, as opposed to an effect on ICS PK. Detection of CYP3A5*3/3, CYPA35*1/*3, and CYP3A5*1/*1 could impact inhaled steroid treatment strategies for asthma in the future.

22 April 2021 in JMIR Preprints
Verified
Preprint
Open access
BPBridget G Parsons
Bridget G Parsons
ENElizabeth S Nagelhout
Elizabeth S Nagelhout
AWAli P Wankier
Ali P Wankier
Nan HuNan Hu
Nan Hu
RLRiley Lensink
Riley Lensink
YWYelena P Wu
Yelena P Wu
BACKGROUND Emerging UV radiation (UVR) monitoring devices may present an opportunity to integrate such technology into skin cancer prevention interventions. However, little is known about the effects of using a wearable UVR monitor on adults’ and children’s sun protection–related behaviors and attitudes (eg, cancer worry and perceived risk). Understanding the potential role of reactivity and seasonal effects will help inform the use of objective monitors in the context of skin cancer prevention research, including intervention studies. OBJECTIVE The aim of this study is to examine the potential reactivity associated with a wearable personal UVR monitor, specifically the effects associated with reported sun-protective behaviors and skin cancer–related attitudes, which are often the targets of skin cancer preventive interventions. METHODS Child-parent dyads (n=97 dyads) were asked to wear a UVR monitoring device during waking hours for 2 weeks. Participants were asked to sync the device daily with a smartphone app that stored the UVR exposure data. Participants were blinded to their UVR exposure data during the 2-week period; thus, the smartphone app provided no feedback to the participants on their UVR exposure. Participants completed self-report questionnaires assessing sun-protective behaviors, sunburn, tanning, skin self-examination, skin cancer–related knowledge, perceived risk, cancer worry, response efficacy, and intentions to change behaviors over the 2-week period. Linear regressions were conducted to investigate changes in the outcomes over time and to account for the role of the season of study participation. RESULTS Regression results revealed that there was a significant decrease over time for several sun protection outcomes in children, including time spent outdoors on weekends (P=.02) and weekdays (P=.008), sunscreen use (P=.03), reapplication (P<.001), and unintentional tanning (P<.001). There were no significant changes over time in children’s and parents’ UVR exposure, sunburn occurrence, or sun protection attitudes. Season of participation was associated with several outcomes, including lower sunscreen use (P<.001), reapplication (P<.001), sunburns (P=.01), intentions to change sun-protective behaviors (P=.02), and intentional (P=.008) and unintentional tanning (P=.01) for participants who participated in the fall versus the summer. CONCLUSIONS The findings from this study suggest that daily use of a UVR monitoring device over a 2-week period may result in changes in certain sun-protective behaviors. These results highlight the importance of identifying and addressing potential reactivity to UVR monitoring devices, especially in the context of skin cancer preventive intervention research. Ultimately, objectively assessed UVR exposure could be integrated into the outcome assessment for future testing of skin cancer prevention interventions. CLINICALTRIAL

22 October 2026 in JMIR Research Protocols
Verified
Journal Article
Open access
FNFlory Nkoy
Flory Nkoy
BSBryan Stone
Bryan Stone
CFCarolyn C. Foster
Carolyn C. Foster
AZAngela Zhu
Angela Zhu
SMSara McCormick
Sara McCormick
NMNancy Murphy
Nancy Murphy
Background: Children with medical complexity (CMC) experience frequent acute health deteriorations, leading to recurrent hospitalizations. Home monitoring has been suggested to help reduce hospitalizations among CMC, yet the benefits have not been demonstrated. MyChildCMC is a novel app, co-designed with parents, that supports CMC home monitoring to identify early warning signs of acute health changes to promote timely intervention. Objective: This study aims to assess the efficacy of the MyChildCMC intervention on child and parent outcomes and the sustainability of MyChildCMC use by parents and of the intervention’s effects. Methods: This is a 12-month, 2-arm randomized controlled trial recruiting 360 CMC (aged 1‐18 years) and their parents: 180 child-parent dyads assigned to the MyChildCMC app and 180 to the control arm. Participants randomized to the MyChildCMC arm use a sensor and digital thermometer to record vital signs (temperature, heart rate, respiratory rate, and oxygen saturation) and symptoms (pain, feeding/fluid intake, mental status, and seizures) in the app daily and receive immediate feedback. Parents receive alerts for early signs of their child’s health deterioration and can view summary reports and individual graphs about the child’s health status in the app. Alerts are also sent to the care team, who can view, via a web-based dashboard, summary reports and individual graphs to support timely care. Participants randomized to the control arm use the sensor/thermometer to record the same clinical parameters daily in a diary. Both arms receive financial incentives for daily monitoring and for responding to surveys at baseline and at 3, 6, and 12 months. The efficacy will be assessed at 6 months. The monitoring incentive will be stopped at 6 months, but participants will continue with daily monitoring for 6 more months to assess sustainability at 12 months. The primary outcome is the number of hospital admissions among CMC. Secondary outcomes are assessed for the child (hospital days and quality of life) and the parent (stress, self-efficacy, and satisfaction with the child’s care). Results: We will determine the extent to which the use (vs controls) of the MyChildCMC app leads to reduced emergency department/hospital admissions among CMC. We will also determine whether MyChildCMC use leads to improvements in secondary outcomes. Before the current full-scale study, we conducted a pilot trial, which showed promising results. However, the study was not powered to detect differences in hospital admissions. A larger, definitive study of MyChildCMC’s impact was needed to confirm these results. Recruitment for the current study started on January 6, 2026, and will end by March 31, 2028. To date, 41 participants have been enrolled. We expect the last participant to complete the study by March 31, 2029, and thereafter we will analyze the data. Conclusions: The MyChildCMC app was designed to support CMC home monitoring and proactive care. If efficacious, it will serve as a new model for reducing hospital admissions, with the potential for broad dissemination.